50
Participants
Start Date
March 1, 2018
Primary Completion Date
December 31, 2019
Study Completion Date
December 31, 2019
Antiretroviral Therapy
All participants receive antiretroviral therapy to control virus replication and restore CD4+ T-cell count.
Peking Union Medical College Hospital, Beijing
Peking Union Medical College Hospital
OTHER